NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers

Complete

Buyers

NHS England

Value

£35,464,756

Classifications

Pharmaceutical products

Tags

tender

Submission Deadline

1 year ago

Published

1 year ago

Description

NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers.<br/>Period of framework agreement: 1st February 2025 to 31st January 2027, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.

Similar Contracts

Open

NHS Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins - 1 June 2026

NHS National Proprietary Pharmaceuticals – Intravenous (IV) Fluids, Topical Solutions, Urological Solutions & Gelatins 1 June 2026 – CM/PHR/25/5727 Period of Framework Agreement: 1 June 2026 to 31 May 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/25/5727/01 - High Use Lines Regionally Awarded to 1 Supplier CM/PHR/25/5727/02 - Not Regionally Awarded Lines CM/PHR/25/5727/03 - All Lines in Lot 1 and Lot 2, available only to Aseptic Units from any Supplier CM/PHR/25/5727/04 - Added Value Services

Published 1 day ago

Open

Surgical Dressings

This tendering exercise aims at renewing the compliant and effective framework for the supply and delivery of Surgical Dressings and Miscellaneous Products [3508540] which is due to expire on 30th April 2026*. This new framework will also incorporate the Aseptically Prepared Larvae which are currently covered by JDAC 4225718 which expires 31st May 2026*. *Both the existing Surgical Dressings FW [3508540] and the Aseptically Prepared Larvae JDAC [4225718] were extended by 3 and 2 months respectively (under clause 2.3, Commercial Terms and Conditions ) to 31st July 2026 allow additional time for completion of this tender.

Published 4 days ago

Open

LW158 IMP Support (FAME)

The purpose of this project is to appoint a supplier to handle the receipt of clinical trial Investigational Medicinal Product (IMP) from manufacturer, import, labelling, and distribution to the in-country sites/teams. The trial will be running in Cameroon and involves three oral drugs. Initial dose will be delivered to remote community clinic or healthcare facility and subsequent doses stored and given from the hospital site during the participant admission. For more information about this opportunity, please visit the Delta eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-Liverpool:-Pharmaceutical-products./93NSCJ7665 To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/93NSCJ7665

Published 1 week ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

NHS England

Body governed by public law

[email protected]

Timeline complete